FY26 Multiple Sclerosis Clinical Trial Award (MSRP) for proof-of-concept or phase 1-2 trials
The FY26 Multiple Sclerosis Research Program Clinical Trial Award (CTA) funds teams to rapidly carry out clinical trials that could meaningfully improve multiple sclerosis treatment or management. Applicants must focus on at least one of the program’s FY26 priority areas, with two tiers available: small proof-of-principle trials (including feasibility and early phases) or larger phase 1/2 tria…
Summary: The fiscal year 2026 (FY26) Multiple Sclerosis Research Program (MSRP) Clinical Trial Award (CTA) supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of multiple sclerosis. All applications …
Funding Source
Awards & funding
Dates
Documents
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers